approved

Приложение 4 на ПЛС от 02.02.2020 г.

Unique identificator:  e32ee62a-20f3-4b49-bfff-c3c71123e114

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-02-03 12:46:35
  • Created by: georgi_sivchev
  • Updated at: 2020-02-03 12:46:35
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Regorafenib EU/1/13/858/002 Stivarga, Film coated tablet, 40, mg, Pack: 3 x 28 Bayer AG, Германия Bayer AG, Германия 4213.66 842.73 5056.39 4% 10 4223.66 844.73 5068.39 16% 25 4248.66 849.73 5098.39 НСР-14781/28.12.2017 предварително изпълнение; НСР-16454/17.08.2018; НСР-19203/12.07.2019 27.07.2019 02.08.2019 Активен 8906
Regorafenib EU/1/13/858/002 Stivarga, Film coated tablet, 40, mg, Pack: 3 x 28 Bayer AG, Германия Bayer AG, Германия 4251.78 850.36 5102.14 4% 10 4261.78 852.36 5114.14 16% 25 4286.78 857.36 5144.14 НСР-14781/28.12.2017 предварително изпълнение; НСР-16454/17.08.2018 01.09.2018 02.09.2018 Неактивен 8906
Regorafenib EU/1/13/858/002 Stivarga, Film coated tablet, 40, mg, Pack: 3 x 28 Bayer AG, Германия Bayer AG, Германия 4251.78 850.36 5102.14 4% 10 4261.78 852.36 5114.14 16% 25 4286.78 857.36 5144.14 НСР-14781/28.12.2017 предварително изпълнение; НСР-16454/17.08.2018 01.09.2018 02.09.2018 Неактивен 8906
Regorafenib EU/1/13/858/002 Stivarga, Film coated tablet, 40, mg, Pack: 3 x 28 Bayer AG, Германия Bayer AG, Германия 4300.62 860.12 5160.74 4% 10 4310.62 862.12 5172.74 16% 25 4335.62 867.12 5202.74 НСР-14781/28.12.2017 предварително изпълнение 28.12.2017 02.01.2018 Неактивен 8906
Regorafenib EU/1/13/858/002 Stivarga, Film coated tablet, 40, mg, Pack: 3 x 28 Bayer AG, Германия Bayer AG, Германия 4300.62 860.12 5160.74 4% 10 4310.62 862.12 5172.74 16% 25 4335.62 867.12 5202.74 НСР-14781/28.12.2017 предварително изпълнение 28.12.2017 02.01.2018 Неактивен 8906
Regorafenib EU/1/13/858/002 Stivarga, Film coated tablet, 40, mg, Pack: 3 x 28 Bayer AG, Германия Bayer AG, Германия 4300.62 860.12 5160.74 4% 10 4310.62 862.12 5172.74 16% 25 4335.62 867.12 5202.74 НСР-14781/28.12.2017 предварително изпълнение 28.12.2017 02.01.2018 Неактивен 8906
Efavirenz EU/1/99/111/011 Stocrin, Film coated tablet, 200, tabl, Pack: 90 Merck Sharp & Dohme B.V., Нидерландия Merck Sharp & Dohme B.V.- The Netherlands 106.2 21.24 127.44 4% 4.25 110.45 22.09 132.54 16% 16.99 127.44 25.49 152.93 Промяна на обстоятелствата НСР-16946/04.10.2018 КЦ-651/05.03.2009 18.03.2009 02.11.2018 Активен 596
Efavirenz EU/1/99/111/011 Stocrin, Film coated tablet, 200, tabl, Pack: 90 Merck Sharp & Dohme Ltd., Обединено Кралство Merck Sharp & Dohme B.V.- The Netherlands 106.2 21.24 127.44 4% 4.25 110.45 22.09 132.54 16% 16.99 127.44 25.49 152.93 КЦ-651/05.03.2009 18.03.2009 18.03.2009 Неактивен 596
Perindopril 20090314 Stopress, Tablet, 8, mg, Pack: 30 Pharmaceutical Works Polpharma S.A. (PL), Полша Pharmaceutical Works POLPHARMA S.A. Poland 8.7 1.74 10.44 7% 0.61 9.31 1.86 11.17 20% 1.74 11.05 2.21 13.26 КЦРР-1513/18.10.2012 02.11.2012 02.11.2012 Активен 1410
Perindopril 20090313 Stopress, Tablet, 4, mg, Pack: 30 Pharmaceutical Works Polpharma S.A. (PL), Полша Pharmaceutical Works POLPHARMA S.A. Poland 4.6 0.92 5.52 7% 0.32 4.92 0.98 5.9 20% 0.92 5.84 1.17 7.01 КЦРР-1513/18.10.2012 02.11.2012 02.11.2012 Активен 1409
Perindopril 20090314 Stopress, Tablet, 8, mg, Pack: 30 Pharmaceutical Works Polpharma S.A. (PL), Полша Pharmaceutical Works POLPHARMA S.A. Poland 8.7 1.74 10.44 7% 0.61 9.31 1.86 11.17 20% 1.74 11.05 2.21 13.26 КЦРР-1513/18.10.2012 02.11.2012 02.11.2012 Неактивен 1410
Perindopril 20090313 Stopress, Tablet, 4, mg, Pack: 30 Pharmaceutical Works Polpharma S.A. (PL), Полша Pharmaceutical Works POLPHARMA S.A. Poland 4.6 0.92 5.52 7% 0.32 4.92 0.98 5.9 20% 0.92 5.84 1.17 7.01 КЦРР-1513/18.10.2012 02.11.2012 02.11.2012 Неактивен 1409
Iodine Ioflupane (123I) EU/1/19/1372/002 Striascan, Solution for injection, 74 MBq/ml - 5 ml, -, Pack: 1 vial, glass CIS Bio International, Франция CIS Bio International, Франция 1054 210.8 1264.8 4% 10 1064 212.8 1276.8 16% 25 1089 217.8 1306.8 НСР-20567/09.01.2020 Предварително изпълнение 09.01.2020 02.02.2020 Активен 16842
Olodaterol 20130417 Striverdi Respimat, Inhalation solution, 2,5, mcg, Pack: 1 respimat inhaler and 1 cartridge (60 doses) Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH &Co.KG, Германия 41.07 8.21 49.28 4% 1.64 42.71 8.54 51.25 16% 6.57 49.28 9.86 59.14 корекц. НСР-7731/17.12.2015 НСР-7563/24.11.2015 (допуска предварително изпълнение); НСР-14917/25.01.2018 02.12.2015 02.03.2018 Заличен 4113
Olodaterol 20130417 Striverdi Respimat, Inhalation solution, 2,5, mcg, Pack: 1 respimat inhaler and 1 cartridge (60 doses) Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH &Co.KG, Германия 41.07 8.21 49.28 4% 1.64 42.71 8.54 51.25 16% 6.57 49.28 9.86 59.14 корекц. НСР-7731/17.12.2015 НСР-7563/24.11.2015 (допуска предварително изпълнение) 02.12.2015 02.12.2015 Неактивен 4113
Fat emulsions ІІ-6806/30.01.2003 г. Structolipid 20% emulsion for intravenous infusion, Emulsion for infusion, Purified structured triglyceride 20 g/100 ml - 250 ml, ml, Pack: 10 Fresenius Kabi AB, Швеция Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden 340.55 68.11 408.66 4% 10 350.55 70.11 420.66 16% 25 375.55 75.11 450.66 НСР-1443/10.10.2013; НСР-16908/28.09.2018 19.11.2013 02.11.2018 Заличен 2218
Fat emulsions ІІ-6806/30.01.2003 г. Structolipid 20% emulsion for intravenous infusion, Emulsion for infusion, Purified structured triglyceride 20 g/100 ml - 250 ml, ml, Pack: 10 Fresenius Kabi AB, Швеция Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden 340.55 68.11 408.66 4% 10 350.55 70.11 420.66 16% 25 375.55 75.11 450.66 НСР-1443/10.10.2013 19.11.2013 19.11.2013 Неактивен 2218
Fat emulsions ІІ-6806/30.01.2003 г. Structolipid 20% emulsion for intravenous infusion, Emulsion for infusion, Purified structured triglyceride 20 g/100 ml - 250 ml, ml, Pack: 10 Fresenius Kabi AB, Швеция Fresenius Kabi AB, SE – 751 74 Uppsala, Sweden 562.03 112.41 674.44 4% 10 572.03 114.41 686.44 16% 25 597.03 119.41 716.44 КЦ-1015/02.07.2009 16.07.2009 16.07.2009 Неактивен 2218
Morphine 20030413 Substitol, prolonged-release capsule, hard, 120, mg, Pack: 30 Mundipharma GmbH, Австрия Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria 71.23 14.25 85.48 4% 2.85 74.08 14.82 88.9 16% 11.4 85.48 17.1 102.58 Промяна на обстоятелства НСР-15297/23.03.2018 КЦ-692/09.03.2009 24.03.2009 02.05.2018 Активен 636
Morphine II-4222/16.02.2009 Substitol, prolonged-release capsule, hard, 120, mg, Pack: 30 Mundipharma GmbH, Австрия Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria 71.23 14.25 85.48 4% 2.85 74.08 14.82 88.9 16% 11.4 85.48 17.1 102.58 КЦ-692/09.03.2009 24.03.2009 24.03.2009 Неактивен 636
Morphine 20030414 Substitol, prolonged‐release capsule, hard, 200, mg, Pack: 30 Mundipharma GmbH, Австрия Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria 101.61 20.32 121.93 4% 4.06 105.67 21.13 126.8 16% 16.26 121.93 24.39 146.32 Промяна на обстоятелства НСР-15299/23.03.2018 КЦ-692/09.03.2009 24.03.2009 02.05.2018 Активен 637
Morphine II-4223/16.02.2009 Substitol, prolonged‐release capsule, hard, 200, mg, Pack: 30 Mundipharma GmbH, Австрия Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria 101.61 20.32 121.93 4% 4.06 105.67 21.13 126.8 16% 16.26 121.93 24.39 146.32 КЦ-692/09.03.2009 24.03.2009 24.03.2009 Неактивен 637
Morphine II-4222/16.02.2009 Substitol, prolonged-release capsule, hard, 120, mg, Pack: 30 Mundipharma GmbH, Австрия Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria 71.23 14.25 85.48 4% 2.85 74.08 14.82 88.9 16% 11.4 85.48 17.1 102.58 КЦ-692/09.03.2009 24.03.2009 24.03.2009 Неактивен 636
Morphine II-4223/16.02.2009 Substitol, prolonged‐release capsule, hard, 200, mg, Pack: 30 Mundipharma GmbH, Австрия Bard Pharmaceutical Ltd., UK; Mundipharma GmbH, Germany; Mundipharma Ges.m.b.H, Austria 101.61 20.32 121.93 4% 4.06 105.67 21.13 126.8 16% 16.26 121.93 24.39 146.32 КЦ-692/09.03.2009 24.03.2009 24.03.2009 Неактивен 637
Metoprolol 20130400 Succiprol, Prolonged release tablet, 47.5 mg (съответстващ на 50 mg metoprolol tartrate), -, Pack: 60 Teva B.V., Нидерландия Merckle GmbH, Германия; Teva Pharma B.V., Нидерландия 6.92 1.38 8.3 7% 0.48 7.4 1.48 8.88 20% 1.38 8.78 1.76 10.54 Прот. № 136/16.09.2015; Промяна на обстоятелствата НСР-17084/26.10.2018 НСР-4584/15.09.2014; НСР-17441/06.12.2018 21.12.2018 02.01.2019 Активен 3169
Showing 14001 to 14026 of 17079 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте